Ravindre Panchia - Concepedia

Author

Ravindre Panchia

Also Known As

Dawood, H., Grinsztejn, Beatriz, Hakim, James G, Hosseinipour, Mina C., Panchia, Ravindre, R Panchia, R. Panchia, Ravindre Panchia, Stevens, Wendy, Swanstrom, Ronald

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

Perinatal HIV Research Unit University of the Witwatersrand Fred Hutch Cancer Center Family Health International 360 Johns Hopkins University

About

Ravindre Panchia is an author at Perinatal HIV Research Unit specializing in hiv, medicine, and sexual health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	2.3K
2	Public Health	8	8	393
3	Social Sciences	4	4	123
4	Nursing	2	2	305
5	Education	1	1	58

Ravindre Panchia

Publications

Citations

H-Index

Page 1

	Year	Citations
Antiretroviral Therapy for the Prevention of HIV-1 Transmission Myron S. Cohen, Ying Qing Chen, Marybeth McCauley, New England Journal of Medicine	2016	1.7K
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial Beatriz Grinsztejn, Mina C. Hosseinipour, Heather J. Ribaudo, The Lancet Infectious Diseases Hptn 052Hiv/aids CounsellingTreatment And PreventionHuman RetrovirusAntiviral Therapy	2014	507
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial Sinéad Delany‐Moretlwe, James P. Hughes, Peter Bock, The Lancet Sexual HealthPhase 3Treatment And PreventionHuman RetrovirusAntiviral Therapy	2022	498
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women Linda‐Gail Bekker, Moupali Das, Quarraisha Abdool Karim, New England Journal of Medicine	2024	358
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial Mark F. Cotton, Avy Violari, Kennedy Otwombe, The Lancet Pediatric EpidemiologyTreatment And PreventionHiv Early AntiretroviralPediatricsPaediatric Medicine	2013	257
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial Ian Sanne, Catherine Orrell, Matthew P. Fox, The Lancet NursingAntiretroviral TherapyAdvanced Practice NurseTreatment And PreventionPatient Safety	2010	250
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial Raphael J. Landovitz, Sue Li, Beatriz Grinsztejn, PLoS Medicine	2018	164
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial Raphael J. Landovitz, Sue Li, Joseph J. Eron, The Lancet HIV Treatment And PreventionPharmacologyAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapy	2020	159
Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples Rochelle P. Walensky, Eric L. Ross, Nagalingeswaran Kumarasamy, New England Journal of Medicine	2013	136
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial Sinéad Delany‐Moretlwe, Carl Lombard, Deborah Baron, The Lancet Infectious Diseases Sexual HealthPhase 3Treatment And PreventionSouth AfricaAntiviral Therapy	2018	94

Page 1